Audicus Omni 2 vs Signia Pure C&G IX

The Audicus Omni 2 is a premium behind-the-ear OTC hearing aid priced at $1,898 that earned an A grade in our lab testing, placing it in the top 6% of the 65 OTC hearing aids we've evaluated. This two-time Expert's Choice Award winner (2023 and 2024) delivers consistently strong performance across multiple listening scenarios. In our testing, the Omni 2 demonstrated particular strength in speech clarity during quiet environments, scoring 4.2/5—a strong result that sits 1.38 points above the category average. Music streaming quality also impressed at 3.6/5, exceeding the category average by 1.68 points. Speech understanding in noisy environments scored 2.3/5, which is above the category average of 1.48 but represents mixed performance in absolute terms—meaning challenging noise situations may still prove difficult. The device offers flexible power options with both rechargeable and disposable batteries, and supports streaming from both iPhone and Android devices with hands-free capability. Feedback handling is excellent at 4.5/5, essentially matching the category average, while own-voice comfort scores a solid 3.0/5. The Audicus Omni 2 is best suited for consumers seeking a premium OTC option with strong everyday speech clarity and quality streaming capabilities. Those frequently in very noisy environments should set realistic expectations, though the device still outperforms most OTC competitors in these conditions.

The Signia Pure C&G IX is a premium prescription behind-the-ear hearing aid released in 2023, currently available at $3,298. In HearAdvisor's lab testing, it earned an A grade with a SoundScore of 4.1/5, ranking #20 among 36 prescription hearing aids tested. This device demonstrates consistent strength across multiple performance areas. Speech in quiet scored a solid 4.0/5, sitting 0.65 points above the category average. Speech in noise performance, while above the category average by 0.25 points, remains mixed in absolute terms at 2.2/5—a common challenge across prescription devices. Feedback handling is a standout feature, achieving a perfect 5.0/5 and exceeding the already-high category average. Own-voice comfort scores a solid 3.2/5, running 0.45 points above the category average, which suggests good occlusion management. Music streaming performs solidly at 3.0/5, also above average for the category by 0.36 points. The device supports both iPhone and Android streaming along with hands-free functionality. Professional tuning yields meaningful improvement, with the normalized score increasing from 4.0/5 to 4.5/5. Buyers seeking top-tier performance in this price range should note that competitors like the Phonak Sphere Infinio (5.0/5) and Oticon Intent (4.85/5) scored higher in our testing. The Pure C&G IX may suit those who prioritize reliable feedback control and balanced everyday performance over maximum speech-in-noise capability.